1. Home
  2. CGEM vs GCT Comparison

CGEM vs GCT Comparison

Compare CGEM & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • GCT
  • Stock Information
  • Founded
  • CGEM 2016
  • GCT 2019
  • Country
  • CGEM United States
  • GCT United States
  • Employees
  • CGEM N/A
  • GCT N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • GCT Catalog/Specialty Distribution
  • Sector
  • CGEM Health Care
  • GCT Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • GCT Nasdaq
  • Market Cap
  • CGEM 530.0M
  • GCT 685.2M
  • IPO Year
  • CGEM 2021
  • GCT 2022
  • Fundamental
  • Price
  • CGEM $7.68
  • GCT $20.73
  • Analyst Decision
  • CGEM Strong Buy
  • GCT Buy
  • Analyst Count
  • CGEM 6
  • GCT 2
  • Target Price
  • CGEM $28.17
  • GCT $20.50
  • AVG Volume (30 Days)
  • CGEM 360.3K
  • GCT 690.1K
  • Earning Date
  • CGEM 08-07-2025
  • GCT 08-05-2025
  • Dividend Yield
  • CGEM N/A
  • GCT N/A
  • EPS Growth
  • CGEM N/A
  • GCT 19.58
  • EPS
  • CGEM N/A
  • GCT 3.07
  • Revenue
  • CGEM N/A
  • GCT $1,181,871,000.00
  • Revenue This Year
  • CGEM N/A
  • GCT $1.98
  • Revenue Next Year
  • CGEM N/A
  • GCT $6.50
  • P/E Ratio
  • CGEM N/A
  • GCT $6.76
  • Revenue Growth
  • CGEM N/A
  • GCT 42.89
  • 52 Week Low
  • CGEM $6.85
  • GCT $11.17
  • 52 Week High
  • CGEM $21.01
  • GCT $32.43
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 45.96
  • GCT 61.16
  • Support Level
  • CGEM $7.29
  • GCT $19.61
  • Resistance Level
  • CGEM $7.94
  • GCT $21.37
  • Average True Range (ATR)
  • CGEM 0.39
  • GCT 0.96
  • MACD
  • CGEM -0.01
  • GCT 0.07
  • Stochastic Oscillator
  • CGEM 61.01
  • GCT 85.68

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.

Share on Social Networks: